Our present results suggest that VD enhances fatty acid oxidation via PPAR‐α in liver, which is in line with the previous study revealing that VD acts as a protective factor in non‐alcoholic fatty liver disease and that VD may alleviate hepatic steatosis via the PPAR‐α signaling pathway (Du et al. 2023). This evidence concerns the gene PPARA and fatty liver disease.